Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".

NCT07390214 is registered in ClinicalTrials.gov with Cardioangiologisches Centrum Bethanien as lead sponsor.

NCT NCT07390214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07390214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".
Lead sponsor
Cardioangiologisches Centrum Bethanien
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2025
Completion date
March 30, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation - symptomatic